Cargando…
Profiles of Independent-Comorbidity Groups in Senior COVID-19 Patients Reveal Low Fatality Associated with Standard Care and Low-Dose Hydroxychloroquine over Antivirals [Letter]
Autores principales: | Gayatri, Sri Wahyuni, Arsal, Andi St Fahirah, Wisudawan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199694/ https://www.ncbi.nlm.nih.gov/pubmed/37215750 http://dx.doi.org/10.2147/JMDH.S420308 |
Ejemplares similares
-
Profiles of Independent-Comorbidity Groups in Senior COVID-19 Patients Reveal Low Fatality Associated with Standard Care and Low-Dose Hydroxychloroquine over Antivirals [Response to Letter]
por: Said, Kamaleldin B, et al.
Publicado: (2023) -
Profiles of Independent-Comorbidity Groups in Senior COVID-19 Patients Reveal Low Fatality Associated with Standard Care and Low-Dose Hydroxychloroquine over Antivirals
por: Said, Kamaleldin B, et al.
Publicado: (2023) -
Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
por: Yu, Bo, et al.
Publicado: (2020) -
Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection
por: Takano, Tomomi, et al.
Publicado: (2020) -
Low-cost zeolitic carriers for delivery of hydroxychloroquine immunomodulatory agent with antiviral activity
por: Olejnik, Anna, et al.
Publicado: (2022)